Efficacy of Nivolumab in Pediatric Cancers With High Mutation Burden and Mismatch-Repair Deficiency
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency
Clin. Cancer Res 2023 May 01;[EPub Ahead of Print], A Das, U Tabori, LC Sambira Nahum, NB Collins, R Deyell, R Dvir, C Faure-Conter, TE Hassall, JE Minturn, M Edwards, E Brookes, V Bianchi, A Levine, SC Stone, S Sudhaman, S Sanchez-Ramirez, AB Ercan, L Stengs, J Chung, L Negm, G Getz, YE Maruvka, B Ertl-Wagner, PS Ohashi, T Pugh, C Hawkins, E Bouffet, DA MorgensternFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.